Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures fell, with Dow futures down 450 points. Argenx sank 8.7% after a Sjögren’s trial was halted for futility; others also slid.
Stocks · News reference
Dauch Q2 Adj. EPS $0.32 Beats $0.17 Estimate, Sales $2.955B Beat $2.812B Estimate
Dauch (NYSE:DCH) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.17 by 77.78 percent. This is a 52.38 percent increase over earnings of $0.21 per share from the same period
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
UBS Maintains Buy on Dauch, Lowers Price Target to $8
UBS maintains Dauch (NYSE:DCH) with a Buy and lowers the price target from $9 to $8.
Jefferies Downgrades Dauch to Hold, Lowers Price Target to $7.1
Jefferies analyst Vanessa Jeffriess downgrades Dauch (NYSE:DCH) from Buy to Hold and lowers the price target from $8.25 to $7.1.
TD Cowen Upgrades Dauch to Buy, Raises Price Target to $10